Research progress of oncolytic virus combined with PD-1/PD-L1 inhibitors

Oncolytic viruses are often used in combination with immune checkpoint inhibitors represented in two ways by programmed cell death 1/programmed cell death-Ligand 1 (PD-1/PD-L1). One is oncolytic virus combined with PD-1/PD-L1 inhibitors, which is modified by gene recombination and natural weak toxic...

Full description

Bibliographic Details

Published in:	Jichu yixue yu linchuang
Main Author:	GAN Zi-ying, TANG Hui
Format:	Article
Language:	Chinese
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2022-04-01
Subjects:	pd-1/pd-l1|immune checkpoint inhibitor|oncolytic therapy
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-4-651.pdf